This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Constellation Energy Corporation
Curbline Properties Corp.
enGene Holdings
Immix Biopharma, Inc.
Intuit Inc.

Constellation Energy Corporation

CEG

0.00

Curbline Properties Corp.

CURB

0.00

enGene Holdings

ENGN

0.00

Immix Biopharma, Inc.

IMMX

0.00

Intuit Inc.

INTU

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Ronald Kamdem downgraded Curbline Properties Corp. (NYSE:CURB) from Overweight to Equal-Weight and announced a $30 price target. Curbline Properties shares closed at $30.01 on Wednesday. See how other analysts view this stock.
  • Stifel analyst Brad Reback downgraded Intuit Inc (NASDAQ:INTU) from Buy to Hold and slashed the price target from $375 to $275. Intuit shares closed at $269.08 on Wednesday. See how other analysts view this stock.
  • Morgan Stanley analyst Judah Frommer downgraded enGene Therapeutics Inc (NASDAQ:ENGN) from Equal-Weight to Underweight. enGene Therapeutics shares closed at $1.74 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Brandon Folkes downgraded Traws Pharma Inc (NASDAQ:TRAW) from Buy to Neutral and announced a $1 price target. Traws Pharma shares closed at $0.80 on Wednesday. See how other analysts view this stock.

Considering buying INTU stock? Here’s what analysts think:

Photo via Shutterstock